Skip to main content
GRND
NYSE Technology

Grindr Q3: Revenue Up 22% to $141.4M, But UK Settlement Swings Quarter to $6.6M Net Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$13.54
Mkt Cap
$2.354B
52W Low
$9.732
52W High
$18.5
52W Position info
39% above low
Off High info
27% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

GRND sits 39% above its 52-week low of $9.732 on elevated volume (2.0× avg).

Summary

Grindr's Q3 revenue rose 22% to $141.4 million with Adjusted EBITDA of $61.7 million, but a $32.8 million UK legal settlement charge pushed the quarter to a $6.6 million net loss. The 10-Q also details the November 2 close of the $250 million PurposeMed acquisition, funded partly with a $152 million revolver draw.


Key Events · Earnings and Guidance · GRND

  • Q3 Revenue Grows 22% to $141.4M

    Revenue rose to $141.4 million from $115.8 million, with app-based revenue up 22.0% to $117.5 million and advertising up 22.7% to $23.8 million; ARPPU rose 9.9% to $27.15.

  • UK Settlement Drives Quarterly Net Loss

    Selling, general and administrative expense jumped 174.4% to $80.4 million on $32.8 million of legal settlement expense, turning $30.8 million of prior-year net income into a $6.6 million net loss.

  • Adjusted EBITDA Up 12.6% to $61.7M

    Adjusted EBITDA rose to $61.7 million from $54.8 million, though margin compressed to 43.7% from 47.4%; nine-month free cash flow was $120.6 million.

  • PurposeMed Deal Closed for $250M

    The acquisition closed November 2, 2026 for $190.0 million cash, 3,851,684 shares valued at approximately $49.2 million, and up to $70.0 million of 2027 earnout; cash came partly from a $152.0 million revolver borrowing on October 30, 2026.


Analysis · GRND · Technology

Revenue growth held up — $141.4 million in Q3, up 22.1% — and Adjusted EBITDA rose 12.6% to $61.7 million, but the bottom line flipped to a $6.6 million net loss from $30.8 million of income a year ago because of $32.8 million of legal settlement expense tied to the UK Group Action. The bigger structural change is the PurposeMed/Freddie acquisition, which closed November 2, 2026 for $190 million cash plus 3.85 million shares (~$49.2 million) and up to $70 million of earnout, funded partly by a $152 million revolver draw that leaves only $47.6 million of revolver capacity. Cash fell to $49.4 million from $87.0 million at year-end even as the company kept buying back stock ($17.7 million more through November 4). The company now carries a regulated healthcare business with new HIPAA, pharmacy and reimbursement risk on top of its dating app.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GRND was trading at $13.54 on NYSE in the Technology sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $9.73 to $18.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRND - Latest Insights

GRND
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $14.07
Real-time Price: $13.17 info
Change: -$0.900 (-6%) info
Market Cap: $2.373B info
GRND
Oct 02, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $13.62
Real-time Price: $13.17 info
Change: -$0.4462 (-3%) info
Market Cap: $2.373B info
GRND
Sep 30, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.40
Real-time Price: $13.17 info
Change: -$2.23 (-14%) info
Market Cap: $2.373B info
GRND
Sep 30, 2026, 4:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $15.40
Real-time Price: $13.17 info
Change: -$2.23 (-14%) info
Market Cap: $2.373B info
GRND
Sep 04, 2026, 5:16 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $15.25
Real-time Price: $13.17 info
Change: -$2.08 (-14%) info
Market Cap: $2.373B info